Iconic Therapeutics Finds $20M
South San Francisco-based Iconic Therapeutics announced this morning that it has raised $20M in a Series B-1 funding round. The funds came from MPM Capital, Lundbeckfond Ventures, and H.I.G. BioVentures. Iconic Therapeutics is developing treatments for serious eye disorders, including age-related macular degeneration (AMD).
posted on Wednesday, April 16, 2014 (Link to more information)
Related companies:
Iconic Brands, Inc.
Related stories:
> Iconic Therapeutics Adds $10M To Series C
> Global Blood Therapeutics Finds $48M
> Global Blood Therapeutics Finds $40.7M For Sickle Cell Treatments
> InCarda Therapeutics Finds $5M
> SteadyMed Therapeutics Finds $3M In Working Capital
silicontap.com Home